For research teamsHelp me find a study
Back to all studies
CompletedNCT06979544

A Blinded, Study Saftey and Efficacy of Oral LPCN 1154A in Women With Postpartum Depression

This study is completed in the United States. It is testing Saftey and Efficacy of Oral LPCN 1154A for depression.

DepressionDrugFrom 15 Years to 45 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT06979544. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

Check the official registry

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 18 sites
  • Advanced Research Center
    Anahiem, California
    Site status: Not listed — confirm with the team
  • Alliance Research Institute
    Canoga Park, California
    Site status: Not listed — confirm with the team
  • MedOne Clinical Research, LLC
    Miami, Florida
    Site status: Not listed — confirm with the team
  • D&H National Research Centers
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Meridian International Research
    Miami Gardens, Florida
    Site status: Not listed — confirm with the team
  • Atlanta Behavioral Research
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • CenExel Research Center
    Decatur, Georgia
    Site status: Not listed — confirm with the team
  • CenExel Research Center
    Savannah, Georgia
    Site status: Not listed — confirm with the team
  • Clinical Research Prime
    Idaho Falls, Idaho
    Site status: Not listed — confirm with the team
  • Cypress Medical Research Center, LLC
    Kansas City, Kansas
    Site status: Not listed — confirm with the team
  • Best Clinical Trials
    New Orleans, Louisiana
    Site status: Not listed — confirm with the team
  • Oasis Clinical Research
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Monroe Biomedical Research
    Monroe, North Carolina
    Site status: Not listed — confirm with the team
  • Suburban Research Associates
    Media, Pennsylvania
    Site status: Not listed — confirm with the team
  • Gadolin Research
    Beaumont, Texas
    Site status: Not listed — confirm with the team
  • New Dawn Wellness and Medical Center
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Maximos OB/GYN
    League City, Texas
    Site status: Not listed — confirm with the team
  • Populace Research
    Provo, Utah
    Site status: Not listed — confirm with the team
In plain English

Key information made simple

What is this study testing?

This study is testing whether LPCN 1154A may be useful for people experiencing depression.

What would participation involve?

Participants may receive LPCN 1154A, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for people with depression.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

Study sites are listed in the registry. Recruitment status can differ between sites. Ask the research team to confirm the location, any in-person visits, time commitment, costs or compensation, and participation criteria.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: June 16, 2025
Recruitment status
Completed
Enrollment listed in the registry
90
Sponsor
Lipocine Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 15 Years to 45 Years
Official registry ID
NCT06979544
Official title
A Randomized, Blinded, Placebo-Controlled Study to Evaluate the Saftey and Efficacy of Oral LPCN 1154A in Women With Postpartum Depression
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT06979544. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving LPCN 1154A, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with depression; age range: From 15 Years to 45 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Lipocine Inc., which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.